Check the time stamp on this data. Updated AI-Generated Signals for Denali Therapeutics Inc. (DNLI) available here: DNLI.

Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Denali Therapeutics (DNLI) announced initiation of dosing in a global Phase 2a clinical study, BEACON, of the investigational drug leucine-rich ...

Pitcairn Co. purchased a new position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) during the 3rd quarter, ...

A number of equities analysts have recently weighed in on DNLI shares. JPMorgan Chase & Co ... that target amyloid beta and HER2. Receive News & Ratings for Denali Therapeutics Daily - Enter ...

Dinner meeting with management to be held in New York on December 4 hosted by B. Riley.Don't Miss our Black Friday Offers:Unlock your investing ...

Denali Therapeutics (NASDAQ:DNLI) Inc. has reached a new 52-week high, with its stock price climbing to $32.17. This milestone reflects a significant surge in investor... Vicki L. Sato ...

Evercore ISI analyst Joshua Schimmer maintained a Buy rating on Denali Therapeutics (NASDAQ:DNLI) on Friday, setting a price target of $111, which is approximately 101.74% above... Jefferies (NYSE ...